Current educational offerings:
Oncolytic therapy, introduced a decade ago, is gaining momentum as a promising treatment for melanoma. Advanced practice providers play a key role in implementing therapies like intralesional injections and require education, skill development, and credentialing support as they adopt oncolytic virotherapy. This APSHO-endorsed curriculum offers didactic content, instructional videos, and future hands-on training opportunities to support the expanded use of oncolytic therapies in clinical practice.